GR861243B - Process for the preparation of oxothiazolidine compound - Google Patents
Process for the preparation of oxothiazolidine compoundInfo
- Publication number
- GR861243B GR861243B GR861243A GR860101243A GR861243B GR 861243 B GR861243 B GR 861243B GR 861243 A GR861243 A GR 861243A GR 860101243 A GR860101243 A GR 860101243A GR 861243 B GR861243 B GR 861243B
- Authority
- GR
- Greece
- Prior art keywords
- alkyl
- sup
- compound
- alkylcarbamoyl
- preparation
- Prior art date
Links
- -1 oxothiazolidine compound Chemical class 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- JXASPPWQHFOWPL-UHFFFAOYSA-N Tamarixin Natural products C1=C(O)C(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 JXASPPWQHFOWPL-UHFFFAOYSA-N 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000005116 aryl carbamoyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Lubricants (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858512163A GB8512163D0 (en) | 1985-05-14 | 1985-05-14 | Oxothiazolidine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR861243B true GR861243B (en) | 1986-08-28 |
Family
ID=10579098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR861243A GR861243B (en) | 1985-05-14 | 1986-05-13 | Process for the preparation of oxothiazolidine compound |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4764514A (esLanguage) |
| EP (1) | EP0203743B1 (esLanguage) |
| JP (1) | JPS61267562A (esLanguage) |
| KR (1) | KR860009009A (esLanguage) |
| AT (1) | ATE60762T1 (esLanguage) |
| AU (1) | AU593247B2 (esLanguage) |
| CA (1) | CA1274515A (esLanguage) |
| DE (1) | DE3677413D1 (esLanguage) |
| DK (1) | DK222386A (esLanguage) |
| ES (2) | ES8800185A1 (esLanguage) |
| FI (1) | FI861935A7 (esLanguage) |
| GB (1) | GB8512163D0 (esLanguage) |
| GR (1) | GR861243B (esLanguage) |
| HU (1) | HU195200B (esLanguage) |
| IL (1) | IL78750A (esLanguage) |
| NO (1) | NO861907L (esLanguage) |
| SU (2) | SU1545941A3 (esLanguage) |
| ZA (1) | ZA863285B (esLanguage) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0755937B2 (ja) * | 1986-07-29 | 1995-06-14 | 日本曹達株式会社 | オキサ（チア）ゾリジン誘導体その製造方法及び殺ダニ剤 |
| CA1322199C (en) * | 1987-07-15 | 1993-09-14 | Masami Eigyo | N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia |
| DE3875073T2 (de) * | 1987-11-20 | 1993-03-11 | Hoechst Roussel Pharma | 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel. |
| US5066665A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Co. | Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors |
| DE4404848A1 (de) * | 1994-02-16 | 1995-08-17 | Hoechst Ag | Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate |
| CA2191874C (en) | 1994-06-03 | 2008-05-20 | Christopher Ian Brightwell | Novel processes and intermediates for the preparation of piperazine derivatives |
| EP0783504B1 (en) * | 1994-09-16 | 2000-03-15 | Novo Nordisk A/S | [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS |
| US5596011A (en) * | 1995-04-06 | 1997-01-21 | Repine; Karen M. | Method for the treatment of macular degeneration |
| US6359134B1 (en) | 1997-05-30 | 2002-03-19 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
| CN1290254A (zh) | 1998-02-05 | 2001-04-04 | 武田药品工业株式会社 | 氨磺酰衍生物及其制备和用途 |
| US6710061B2 (en) | 2001-03-09 | 2004-03-23 | Ortho-Mcneil Pharamceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
| US6538017B2 (en) | 2001-03-09 | 2003-03-25 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
| US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3309377A (en) * | 1964-10-19 | 1967-03-14 | Sterling Drug Inc | 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation |
| IT1194793B (it) * | 1981-05-12 | 1988-09-28 | Corvi Camillo Spa | Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati |
| DE3315424A1 (de) * | 1983-04-28 | 1984-12-20 | Cassella Ag, 6000 Frankfurt | Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung |
| FR2552762B1 (fr) * | 1983-09-30 | 1986-07-25 | Delalande Sa | Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique |
| PT83152B (pt) * | 1985-08-09 | 1989-03-30 | Lilly Co Eli | Processo para a preparacao de compostos di-t-butilfenoicos |
-
1985
- 1985-05-14 GB GB858512163A patent/GB8512163D0/en active Pending
-
1986
- 1986-04-24 US US06/855,904 patent/US4764514A/en not_active Expired - Fee Related
- 1986-04-30 CA CA000507952A patent/CA1274515A/en not_active Expired - Lifetime
- 1986-05-01 ZA ZA863285A patent/ZA863285B/xx unknown
- 1986-05-07 EP EP86303458A patent/EP0203743B1/en not_active Expired - Lifetime
- 1986-05-07 DE DE8686303458T patent/DE3677413D1/de not_active Expired - Lifetime
- 1986-05-07 AT AT86303458T patent/ATE60762T1/de not_active IP Right Cessation
- 1986-05-08 AU AU57276/86A patent/AU593247B2/en not_active Ceased
- 1986-05-09 FI FI861935A patent/FI861935A7/fi not_active Application Discontinuation
- 1986-05-11 IL IL78750A patent/IL78750A/xx unknown
- 1986-05-13 HU HU861972A patent/HU195200B/hu not_active IP Right Cessation
- 1986-05-13 JP JP61110095A patent/JPS61267562A/ja active Granted
- 1986-05-13 KR KR1019860003700A patent/KR860009009A/ko not_active Withdrawn
- 1986-05-13 GR GR861243A patent/GR861243B/el unknown
- 1986-05-13 DK DK222386A patent/DK222386A/da not_active Application Discontinuation
- 1986-05-13 SU SU864027524A patent/SU1545941A3/ru active
- 1986-05-13 NO NO86861907A patent/NO861907L/no unknown
- 1986-05-13 ES ES554901A patent/ES8800185A1/es not_active Expired
-
1987
- 1987-05-13 SU SU874202533A patent/SU1493107A3/ru active
- 1987-08-13 ES ES557660A patent/ES8802503A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8802503A1 (es) | 1988-07-16 |
| SU1493107A3 (ru) | 1989-07-07 |
| DE3677413D1 (de) | 1991-03-14 |
| HUT41014A (en) | 1987-03-30 |
| KR860009009A (ko) | 1986-12-19 |
| HU195200B (en) | 1988-04-28 |
| FI861935A0 (fi) | 1986-05-09 |
| US4764514A (en) | 1988-08-16 |
| CA1274515A (en) | 1990-09-25 |
| ZA863285B (en) | 1986-12-30 |
| AU5727686A (en) | 1986-11-20 |
| ES8800185A1 (es) | 1987-11-01 |
| ATE60762T1 (de) | 1991-02-15 |
| ES557660A0 (es) | 1988-07-16 |
| EP0203743A1 (en) | 1986-12-03 |
| ES554901A0 (es) | 1987-11-01 |
| IL78750A0 (en) | 1986-08-31 |
| EP0203743B1 (en) | 1991-02-06 |
| JPS61267562A (ja) | 1986-11-27 |
| GB8512163D0 (en) | 1985-06-19 |
| IL78750A (en) | 1990-12-23 |
| FI861935A7 (fi) | 1986-11-15 |
| NO861907L (no) | 1986-11-17 |
| AU593247B2 (en) | 1990-02-08 |
| JPH0455431B2 (esLanguage) | 1992-09-03 |
| DK222386D0 (da) | 1986-05-13 |
| DK222386A (da) | 1986-11-15 |
| SU1545941A3 (ru) | 1990-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL93050A0 (en) | Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL107426A0 (en) | Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| ZA863285B (en) | Oxothiazolidine compound | |
| ES474288A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos | |
| IL98872A0 (en) | Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL109615A (en) | Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GR3017128T3 (en) | Treatment of hiv infections and compounds useful therein. | |
| IL66511A0 (en) | Novel 6alpha-methylprednisolone derivatives,processes for their preparation and pharmaceutical preparations containing them | |
| IL112098A0 (en) | Sulfamate derivatives and pharmaceutical compositions containing them | |
| HUT38097A (en) | Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances | |
| GB8401093D0 (en) | Cephem compounds | |
| GB8504072D0 (en) | Cephem compounds | |
| PT86232A (en) | Process for preparing a pharmaceutical composition containing a9-substituted guanine | |
| IL93594A0 (en) | Pharmaceutical compositions containing an imidazopyrimidone derivative | |
| CA2102812A1 (en) | Cholesterol-lowering tocopherol analogs | |
| WO1987004435A3 (en) | Xanthine compounds | |
| ES8301233A1 (es) | Un procedimiento para la preparacion de antibioticos de b-lactama. | |
| EP0306863A3 (en) | New cephem compounds and processes for preparation thereof | |
| BG95629A (en) | Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations | |
| IL80558A0 (en) | Cephalosporin derivatives and process for their preparation | |
| ES8306152A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno. | |
| GR850484B (esLanguage) |